Where does Selecta Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Selecta Biosciences, Inc. ranks #10,748 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Selecta Biosciences, Inc. hold?

Selecta Biosciences, Inc. holds 29 US utility patents granted between 2015 and 2023, spanning 14 technology areas.

What is Selecta Biosciences, Inc.'s Innovation Score?

Selecta Biosciences, Inc. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Selecta Biosciences, Inc. focus on?

Selecta Biosciences, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 29 patents, ranking #678 of 6,058 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is Selecta Biosciences, Inc.'s patent grant rate increasing or decreasing?

Selecta Biosciences, Inc.'s recent grant velocity is -62% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Selecta Biosciences, Inc.'s patents?

Selecta Biosciences, Inc.'s patents average 17.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Selecta Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Selecta Biosciences, Inc.

USPTO PatentsView assignee record - 29 granted patents across 14 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Selecta ranks #10,748 of 49,997 tracked US assignees by granted-patent volume, with 29 patents across 14 technology areas.

#10,748
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 17.8
avg claims per patent: -62%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10748 · US Corporation #10,748 · 29 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 29 grants
UPPER-Q #10,748/49,997
PHOTO-FINISH Satori Worldwide
CPC-FOCUS A61P · 14 areas
INNOV-PAR 40.6/100
CLAIMS-RICH 17.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -62% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Satori Worldwide, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Selecta’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.7 pts (29%) Velocity 5.0 pts (12%) Breadth 13.2 pts (33%) Claim depth 10.7 pts (26%)

Qualcomm Incorporated · highest

85
Airex · near

41
Fluidity · near

41
OBI Pharma · near

41
Oscor · near

41
Selecta Biosciences · this assignee

41
3D Lighting… · lowest

7

What this shows Selecta's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Selecta?

Each dot is one of Selecta’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Selecta’s own 17.8 claims/patent is ABOVE the 14.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Selecta vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Selecta's grants concentrate

Selecta Biosciences, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 100% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2018 (8 grants) versus a trough of 1 in 2017. By volume, Selecta sits between Satori Worldwide, LLC and Shenzhen Kean Silicone Product Co., Ltd..

Selecta's three-year grant acceleration

Selecta Biosciences, Inc. shows 6 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Satori Worldwide

29
Scholar Rock

29
Seasons 4

29
Secturion Systems

29
Shanghai Geely Di…

29
Shanghai Oxi Tech…

29
Shenzhen Envision…

29
Shenzhen Kean Sil…

29
Selecta Bioscienc… ◀

29

What this shows Selecta holds 29 patents at rank #10,762, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Selecta

By rank, the assignees closest to #10,762 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Selecta's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Selecta, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Selecta ranks #678 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

OBI Pharma, Inc. 41 Oscor Inc. 41 Airex Co., Ltd. 41 Fluidity Technologies Inc. 41

Selecta's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Selecta Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.9%
2016	4	13.8%
2017	1	3.4%
2018	8	27.6%
2019	6	20.7%
2020	1	3.4%
2021	1	3.4%
2022	3	10.3%
2023	3	10.3%

Which technologies does Selecta Biosciences, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 29

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 29

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 16

Y02A - Technologies FOR Adaptation TO Climate Change 16

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 13

C12Y - Enzymes 7

C07K - Peptides 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 3

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 3

C07D - Heterocyclic Compounds 3

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 2

Y10T - Technical Subjects Covered BY Former US Classification 1

C08L - Compositions OF Macromolecular Compounds 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Selecta Biosciences, Inc.'s patent record in context - here's where to go next.

Selecta Biosciences, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 100% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #10,748 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Selecta Biosciences, Inc. against Satori Worldwide, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.